Research Into How Cells ‘Self-Destruct’ Maps Out Body’s Defenses Against Viruses

Anti-viral immunity identified a novel mechanism in necroptosis


Researchers at Cleveland Clinic’s Center for Pathogen & Human Health Research have identified a novel mechanism for how the body defends itself against viruses using programmed cell destruction.


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

A study published in Nature Cell Biology identified a new role for the protein OASL in necroptosis, where cells self-destruct to prevent viruses from surviving and replicating. Necroptosis controls viral replication and causes inflammation, putting the body into a state of strong and efficient defense to clear the virus, said Shin Ae Lee, PhD, first author on the paper and a postdoctoral fellow in Cancer Biology.

Mapping out the mechanisms behind defense strategies like necroptosis supports future studies into host-pathogen standoff, a tug-of-war in the immune system during virus infection. Research into these detailed pathways is essential for understanding how viruses infect and survive in humans, and can translate into treatments or vaccines.

Numerous viruses are known to trigger necroptosis, including influenza A virus, cytomegalovirus and herpes simplex virus-1, a widespread virus estimated to effect as much as 80% of the population. Immune responses like necroptosis prevent prolonged infection. Viruses spending more time in the body can cause chronic symptoms and long-term damage, as the body sustains inflammation to fight off the virus.

Dr. Lee works in a lab led by Jae Jung, PhD, chair of the Cancer Biology Department, director of the Infection Biology program, and director of the Global Center for Pathogen & Human Health Research. The Jung Lab studies virus-induced cancers and infectious diseases and how pathogens spread and cause disease.

Necroptosis was recently identified as a critical anti-viral innate immune response, but mechanistic details were unclear. This study found a novel regulator of necroptosis, OASL, acts as a “chaperone” for building the necrosome, a protein complex that mediates cell death. OASL forms phase-separated liquid droplets that attract the molecular components necessary to induce necroptosis, providing a platform for these interactions to take place.


What could this tell us?

Part of Dr. Lee’s research is studying how some viruses, such as vaccinia virus, evade necroptosis. Vaccinia is in the same family as the virus that causes smallpox, and is used to vaccinate against smallpox. Some viruses can knock out, or even mimic, proteins in host cells that disable defenses like necroptosis.

Researchers still don’t know the details of what allows vaccinia to evade necroptosis, but understanding the necroptosis pathway supports further investigation.

“This viral immune evasion mechanism may provide insights into how other viruses utilize a similar method to evade the anti-viral necroptosis pathway,” Dr. Lee says. “For example, the current emerging virus, Mpox, belongs to the same family of viruses as vaccinia virus, and may utilize similar methods for host immune evasion.”

Mpox, formerly known as monkeypox, caused nearly 30,000 U.S. cases and 20 deaths in 2022, according to the Centers for Disease Control and Prevention.

Necroptosis is associated with many human diseases with inflammatory processes outside of viruses, including cancer, sepsis, neurodegenerative diseases and atherosclerosis. Further research may also show OASL-mediated necroptosis is involved in these processes, Dr. Lee says.


This work was partly supported by NIH grant numbers CA200422, CA251275, AI140718, AI140705, AI140705S1, AI152190, AI171443, AI171201, DE023926, DE028521 and KGM9942011.

Editor’s Note: This article was originally published by Cleveland Clinic Lerner Research Institute.

Related Articles

New Data Suggest Kidney Diseases With No Known Cause May Be Linked to Viruses

Using sequencing data to identify novel factors linked to kidney disease with unknown origin

patient in ICU
Cleveland Clinic and Purdue Seek to Revolutionize Intensive Care Through AI

Investigators are developing a deep learning model to predict health outcomes in ICUs.

Researchers Identify Promising Compound for IBD Treatment

Cleveland Clinic and Johns Hopkins collaboration could help meet need for new therapies

Discovering the Clever Way that Flaviviruses Boost Their Own Replication

Cleveland Clinic researchers’ finding paves the way for new antiviral approaches

Pairing Deep Learning With Wide-Field Microscopy to Refine Study of Brain Tissue

Multicenter collaboration aims to facilitate tracking of neurological activity deep within tissue

23-CCC-3906442 MCEMP1 asthma research 650×450
Research Links Immune Cell Receptors to Asthma, Inflammatory Lung Disease

Findings illuminate MCEMP1 protein’s role in severe inflammation

LRI_2875909_04-21-22_Ted Ross
Where We’re Headed with Vaccine Research: A Conversation with Ted Ross, PhD

Cleveland Clinic’s new Global Director of Vaccine Development outlines plans, priorities

Research Aims to Prevent Future Pandemics

Collaborative involving Cleveland Clinic investigators focuses on antiviral drug development